Quarterly report · Q3
3583.TEDINET S100SSAY
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥400m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥507m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥418m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥639m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥519m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥417m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥561m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥297m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥469m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥365m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥297m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥365m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥9.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥3.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥106.79 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.59 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.17 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.72 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.34 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 64.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥861,000 |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥103m |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥535m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥861,000 |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥638m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥861,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥638m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥73m |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥644m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥717m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥717m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating income | Prior1YTDDuration | 25734000 | JPY |
| Non operating income | CurrentYTDDuration | 29902000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 10045000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 12153000 | JPY |
| Other noe | Prior1YTDDuration | 2806000 | JPY |
| Other noe | CurrentYTDDuration | 540000 | JPY |
| Non operating expenses | Prior1YTDDuration | 12851000 | JPY |
| Non operating expenses | CurrentYTDDuration | 12693000 | JPY |
| Ordinary income | Prior1YTDDuration | 519428000 | JPY |
| Ordinary income | CurrentYTDDuration | 417531000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 64878000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | - | JPY |
| Extraordinary income | Prior1YTDDuration | 64878000 | JPY |
| Extraordinary income | CurrentYTDDuration | - | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 22869000 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | - | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 122000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 385000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 22992000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 385000 | JPY |
| Income before income taxes | Prior1YTDDuration | 561314000 | JPY |
| Income before income taxes | CurrentYTDDuration | 417146000 | JPY |
| Income taxes current | Prior1YTDDuration | 108053000 | JPY |
| Income taxes current | CurrentYTDDuration | 116621000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 88057000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 3348000 | JPY |
| Income taxes | Prior1YTDDuration | 196110000 | JPY |
| Income taxes | CurrentYTDDuration | 119969000 | JPY |
| Profit loss | Prior1YTDDuration | 365204000 | JPY |
| Profit loss | CurrentYTDDuration | 297176000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 365204000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 297176000 | JPY |
| Profit loss | Prior1YTDDuration | 365204000 | JPY |
| Profit loss | CurrentYTDDuration | 297176000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 7581000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 128000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | -7551000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 10874000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 29000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 11002000 | JPY |
| Comprehensive income | Prior1YTDDuration | 365234000 | JPY |
| Comprehensive income | CurrentYTDDuration | 308179000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 365234000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 308179000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember | 2907611000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember | 1057414000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 3965025000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3965025000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember | 3428000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |